Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » Shareholder Update
Shareholder Update
August 7, 2015 •
Category
•
Author Name
S
hareholder Update
Latest News
2024 AGM CEO Presentation
December 3, 2024
2024 AGM CEO Presentation
Read More
2024 AGM Chairman’s Address
December 3, 2024
2024 AGM Chairman’s address
Read More
